IOL CHEMICALS & PHARM. | PHARMAIDS PH | IOL CHEMICALS & PHARM./ PHARMAIDS PH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | -21.6 | - | View Chart |
P/BV | x | 1.6 | 9.4 | 16.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. PHARMAIDS PH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PHARMAIDS PH Mar-23 |
IOL CHEMICALS & PHARM./ PHARMAIDS PH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 32 | 1,653.9% | |
Low | Rs | 272 | 10 | 2,676.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 0 | - | |
Earnings per share (Unadj.) | Rs | 23.7 | -3.5 | -674.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -3.5 | -899.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 10.3 | 2,495.7% | |
Shares outstanding (eoy) | m | 58.71 | 21.49 | 273.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0 | - | |
Avg P/E ratio | x | 17.1 | -6.1 | -281.6% | |
P/CF ratio (eoy) | x | 12.8 | -6.1 | -211.0% | |
Price / Book Value ratio | x | 1.6 | 2.1 | 76.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 458 | 5,185.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 11 | 14,872.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 0 | - | |
Other income | Rs m | 256 | 0 | - | |
Total revenues | Rs m | 22,427 | 0 | - | |
Gross profit | Rs m | 2,257 | -99 | -2,282.7% | |
Depreciation | Rs m | 462 | 0 | 271,529.4% | |
Interest | Rs m | 165 | 0 | 329,400.0% | |
Profit before tax | Rs m | 1,887 | -99 | -1,904.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -24 | -2,105.0% | |
Profit after tax | Rs m | 1,391 | -76 | -1,841.5% | |
Gross profit margin | % | 10.2 | 0 | - | |
Effective tax rate | % | 26.2 | 23.7 | 110.6% | |
Net profit margin | % | 6.3 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 175 | 5,519.6% | |
Current liabilities | Rs m | 5,025 | 21 | 23,625.8% | |
Net working cap to sales | % | 20.9 | 0 | - | |
Current ratio | x | 1.9 | 8.2 | 23.4% | |
Inventory Days | Days | 43 | 0 | - | |
Debtors Days | Days | 8 | 0 | - | |
Net fixed assets | Rs m | 11,017 | 42 | 25,941.6% | |
Share capital | Rs m | 587 | 214 | 273.8% | |
"Free" reserves | Rs m | 14,490 | 7 | 216,593.4% | |
Net worth | Rs m | 15,077 | 221 | 6,818.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 219 | 9,453.3% | |
Interest coverage | x | 12.5 | -1,980.6 | -0.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0 | - | |
Return on assets | % | 7.5 | -34.5 | -21.8% | |
Return on equity | % | 9.2 | -34.2 | -27.0% | |
Return on capital | % | 13.6 | -44.8 | -30.4% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -40 | -3,042.3% | |
From Investments | Rs m | -1,200 | -49 | 2,427.7% | |
From Financial Activity | Rs m | -41 | 213 | -19.3% | |
Net Cashflow | Rs m | -18 | 123 | -14.9% |
Indian Promoters | % | 48.2 | 5.6 | 854.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 94.4 | 54.9% | |
Shareholders | 130,003 | 7,567 | 1,718.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | PHARMAIDS PH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.46% | -1.30% | -0.52% |
1-Month | 6.02% | 11.49% | -0.61% |
1-Year | -1.94% | 103.17% | 52.98% |
3-Year CAGR | -12.90% | 56.54% | 14.71% |
5-Year CAGR | 17.49% | 64.22% | 19.67% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the PHARMAIDS PH share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of PHARMAIDS PH the stake stands at 5.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of PHARMAIDS PH.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
PHARMAIDS PH paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of PHARMAIDS PH.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.